Very curious about Xenex. Contrary to what Dr. Shannon said it looks like they have been published in a peer reviewed journal - www.xenex.com/wp-content/uploads/2011/02/ICHE-Stibich.pdf - "Infection Control and Hospital Epidemiology publishes scientifically authoritative, clinically applicable, peer-reviewed research"
They have several cases where their customers have claimed a significant reduction in HAI's. Though the level of reduction of bacteria might not be as significant as Asepticsure it seems they are gettings the results we would hope that Aspeticsure can produce. What I can't figure out is if the product they have is working why aren't more hospitals buying it and does their tough sell have any implications for Asepticsure's marketing potential?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.